Salmonellosis laboratory tests

Revision as of 03:05, 22 August 2014 by Joao Silva (talk | contribs)
Jump to navigation Jump to search

Salmonellosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Salmonellosis from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Treatment

Medical Therapy

Primary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Salmonellosis laboratory tests On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Salmonellosis laboratory tests

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Salmonellosis laboratory tests

CDC on Salmonellosis laboratory tests

Salmonellosis laboratory tests in the news

Blogs on Salmonellosis laboratory tests

Directions to Hospitals Treating Salmonellosis

Risk calculators and risk factors for Salmonellosis laboratory tests

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: João André Alves Silva, M.D. [2] Jolanta Marszalek, M.D. [3]

Overview

Laboratory Findings

Determining that Salmonella is the cause of the illness depends on laboratory tests that identify Salmonella in the stools of an infected person. These tests are sometimes not performed unless the laboratory is instructed specifically to look for the organism. Once Salmonella has been identified, further testing can determine its specific type, and which antibiotics could be used to treat it.

The table below displays the nonspecific laboratory abnormalities associated with Ebola infection, including:[1]

Laboratory findings
Test Findings
White blood cell count Leucopenia
Lymphopenia
Neutrophilia
Blood smear Left shift
Atypical lymphocytes
Coagulation Consumption of clotting factors
Increased concentrations of fibrin degradation products
Liver function tests Raised aspartate aminotransferase
Raised alanine aminotransferase
Extended prothrombin time
Extended partial thromboplastin time
Proteins Hyperproteinemia
Urinalysis Proteinuria

References

  1. Feldmann H, Geisbert TW (2011). "Ebola haemorrhagic fever". Lancet. 377 (9768): 849–62. doi:10.1016/S0140-6736(10)60667-8. PMC 3406178. PMID 21084112.


Template:WikiDoc Sources